Our results confirmed that the expression level of CCL18 in pancreatic cancer was significantly higher than that in corresponding normal pancreatic tissues and that CCL18 is the most abundantly expressed cytokine in IL-4-activated M2 macrophages. Here, CCL18 is linked to pancreatic neoplasm.